EPAP at the European Medicines Agency (EMA)

On 26 November Kerstin from ELF Kerstin from ELF attended the next day, presenting EPAP in a session about European patient-led patient raining to a room full of European patient organisations interested in patient training.

The day before this,  ELF and Patient Ambassador Ewelina Szmytke, who is involved in one of the ELF’s Patient Priority Projects, took part in the annual patient training day at the EMA. This was an interactive training day to gain knowledge of how and when patients can take part in EMA activities throughout the lifecycle of a medicine. 

The training provided information and hands-on experience about how medicines are evaluated at the EMA and how patients are involved both in the processes leading up to authorisation of a medicine as well as in the marketing of the medicine once it has been authorised.

Ewelina said: “I found the training very useful. The knowledge will give us the ability to discuss with other stakeholders with much more confidence and will enable us to influence the procedure of drug implementation in the parts it can be influenced by patients. That’s a priceless knowledge”.

Kerstin from ELF attended the next day, presenting EPAP in a session about European patient-led patient raining

The EMA is a decentralised agency of the European Union, located in London. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union.